Uncategorized

3 Jul, 2018

Xtalks Webinar: Overcoming the Challenges of Immuno-Oncology Biomarker Discovery: From Sample to Analytics

Xtalks Webinar: Overcoming the Challenges of Immuno-Oncology Biomarker Discovery: From Sample to Analytics Only 20% of patients respond to cancer immunotherapies and determining which patients will respond to which treatment options relies on the identification of predictive biomarkers. Immuno-oncology biomarkers such as tumor mutational burden (TMB) or PD-L1 expression are promising, but have [...]

Go to Top